Atlas Trials

Prophylactic Intravesical Chemotherapy to Prevent Bladder Recurrence After Nephroureterectomy for Primary Upper Tract Urothelial Carcinoma Patients

Clinical trial NCT02923557 · UNKNOWN

Trial details

NCT number
NCT02923557
Sponsor
Peking University First Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Bladder RecurrenceUpper Tract Urothelial CarcinomaNephroureterectomy
Start date
2016-11-01
Primary completion
2021-11-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.